Swiss National Bank’s BridgeBio Pharma BBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $11M | Buy |
254,400
+16,400
| +7% | +$708K | 0.01% | 872 |
|
|
2025
Q1 | $8.23M | Sell |
238,000
-2,300
| -1% | -$79.5K | 0.01% | 990 |
|
|
2024
Q4 | $6.59M | Buy |
240,300
+21,000
| +10% | +$576K | ﹤0.01% | 1155 |
|
|
2024
Q3 | $5.58M | Buy |
219,300
+2,400
| +1% | +$61.1K | ﹤0.01% | 1263 |
|
|
2024
Q2 | $5.49M | Buy |
216,900
+10,900
| +5% | +$276K | ﹤0.01% | 1218 |
|
|
2024
Q1 | $6.37M | Buy |
206,000
+29,900
| +17% | +$925K | ﹤0.01% | 1145 |
|
|
2023
Q4 | $7.11M | Sell |
176,100
-18,000
| -9% | -$727K | 0.01% | 1073 |
|
|
2023
Q3 | $5.12M | Buy |
194,100
+2,300
| +1% | +$60.7K | ﹤0.01% | 1260 |
|
|
2023
Q2 | $3.3M | Buy |
191,800
+46,600
| +32% | +$802K | ﹤0.01% | 1574 |
|
|
2023
Q1 | $2.41M | Sell |
145,200
-15,900
| -10% | -$264K | ﹤0.01% | 1723 |
|
|
2022
Q4 | $1.23M | Buy |
161,100
+4,600
| +3% | +$35.1K | ﹤0.01% | 2232 |
|
|
2022
Q3 | $1.56M | Hold |
156,500
| – | – | ﹤0.01% | 2044 |
|
|
2022
Q2 | $1.42M | Buy |
156,500
+17,300
| +12% | +$157K | ﹤0.01% | 2153 |
|
|
2022
Q1 | $1.41M | Sell |
139,200
-9,300
| -6% | -$94.4K | ﹤0.01% | 2230 |
|
|
2021
Q4 | $2.48M | Hold |
148,500
| – | – | ﹤0.01% | 1914 |
|
|
2021
Q3 | $6.96M | Buy |
148,500
+800
| +0.5% | +$37.5K | ﹤0.01% | 1227 |
|
|
2021
Q2 | $9M | Buy |
147,700
+28,400
| +24% | +$1.73M | 0.01% | 1069 |
|
|
2021
Q1 | $7.35M | Buy |
+119,300
| New | +$7.35M | ﹤0.01% | 1205 |
|